Nadine Rouphael

Co-Director of the Stimulating Access to Research in Residency (StARR) R38 Program · Emory School of Medicine

Credentials: · ·

History

Stimulating Access to Research in Residency (StARR) R38 Program Residency · Emory School of Medicine
Present
T32 vaccinology grant · Emory School of Medicine
Present
Emory University School of Medicine
Present

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2021 · 8,425 citations
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report
New England Journal of Medicine · 2020 · 2,556 citations
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
New England Journal of Medicine · 2021 · 1,404 citations

Drivers of Influenza A Virus Transmission in Humans
National Institute of Allergy and Infectious Diseases · P01
Project lead · $827.1K · Emory University
2025–2030
Training a New Generation of Vaccinologists
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $2.2M · Emory University
2009–2029
Emory R38 Research Training Program
National Institute of Allergy and Infectious Diseases · R38
Contact PI · $1.4M · Emory University
2023–2029
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae
NIH Office of the Director · N01
Contact PI · $12.1M · University of Alabama at Birmingham
2017–2027

A Human Influenza Transmission Study Using Naturally Infected Community Donors
Principal investigator · Not yet recruiting
Emory University
2026–2031
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
Principal investigator · Recruiting · Phase 1, Phase 2
Cocrystal Pharma, Inc.
2026
Systems Biological Analysis of Immune Responses to RSV Vaccine
Principal investigator · Active not recruiting · Phase 4
Emory University
2025–2027
A/Texas Flu Challenge
Principal investigator · Recruiting · Phase 1
Emory University
2025–2027